FDA Advisory Panel Asks for Improvements in Pulse Oximeters

An FDA Anesthesiology and Respiratory Therapy Devices advisory panel met this week to discuss racial and skin-pigmentation bias in pulse oximeter devices. This comes in the wake of research demonstrating that inaccurate blood oxygen readings may have contributed to the greater number of Covid-19 deaths in minority patients compared to white patients.

View More FDA Advisory Panel Asks for Improvements in Pulse Oximeters